Newbridge Financial Services Group, Inc. - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 198 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
Newbridge Financial Services Group, Inc. ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$3,000
+200.0%
440.0%0.00%
+100.0%
Q2 2022$1,000
-50.0%
440.0%0.00%0.0%
Q1 2022$2,000
+100.0%
440.0%0.00%
Q4 2021$1,0000.0%440.0%0.00%
-100.0%
Q3 2021$1,000
-50.0%
440.0%0.00%0.0%
Q2 2021$2,0000.0%440.0%0.00%0.0%
Q1 2021$2,000440.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q2 2021
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders